The cannabis information platform Leafly announced a strategic partnership Tuesday with the American Medical Marijuana Physicians Association, the world’s largest physician-based cannabis association.
The partnership is focused on helping physicians provide cannabis-based care to patients.
The collaboration follows an increase in demand for cannabinoid-based medicines, with 33 states legalizing medical cannabis and more than 90% of Americans being in favor of federal legalization.
More Medical Cannabis Creates A Greater Need For Information
As part of the partnership, Leafly will offer physicians a subscription that includes a presence on its site, as well as an AMMPA membership.
The two organization will also collaborate on events that promote medical cannabis education, as well as an online learning course that deals with medical cannabis topics.
A vast majority of Americans are in favor of legal medical cannabis, Leafly CEO Tim Leslie told Benzinga.
"As this support has grown, so too has the need for information and education," he said.
"Leafly is proud to be a trusted resource for finding safe and legal adult-use recreational and medicinal cannabis."
The partnership with the AMMPA is "the next step" in building education and trust, the CEO said.
With 2 million Americans now having legal access to medical cannabis, the AMMPA is excited to partner with Leafly to ensure that health care providers have trusted, reliable information, said Dr. Mark Chaet, the organization's president.
"We want to help equip doctors with the best patient care tools available to them, and in particular the untapped potential of medicinal cannabinoids. Through this partnership, we’re looking forward to educating and empowering the entire medical community, and establishing cannabinoids as a trusted and accessible form of care."
Related Links:
Exclusive: Leafly Launches Cannabis Lab Testing Certification Program
Beyond Indica And Sativa: Leafly Launches Graphic Platform For Identifying Cannabis Strains
Photo courtesy of Leafly.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.